eMultipleSclerosis Review
Mitigating MS DMT Infection Risk
August 03, 2023
Clinicians prescribing the increasingly higher efficacy B-cell depletion or S1P modulators therapies how aware are they of the newer concerns about safety? Which of their patients may be in greater danger of acquiring PML and/or opportunistic infections
New York
EMultipleSclerosis Review podcast channel
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast